Andere Sprachen LSL Pharma Group Inc.

Aktien

LSL

CA50190N1042

LSL

Schlusskurs Toronto S.E. Andere Börsenplätze 00:00:00 07.06.2024			% 5 Tage	% 1. Jan.
0,5 ^CAD	+2,04 %		-1,96 %	+3,09 %

05.06.	LSL Pharma will $4,5 Millionen über Privatplatzierungen einnehmen	MT
30.05.	LSL Pharma Group Inc. meldet Ergebniszahlen für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

LSL Pharma to Raise $4.5 Million Via Private Placements	05.06.
LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $4.5 Million	05.06.
LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $4.5 Million	05.06.
LSL Pharma Group Inc. announced that it expects to receive CAD 3 million in funding	05.06.
LSL Pharma Group Reports Record Revenues and Margins for the First Quarter 2024	30.05.
LSL Pharma Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	30.05.
LSL Pharma Group Announces Listing of Convertible Redeemable Debentures on the TSXV	22.05.
LSL Pharma to Acquire Quebec Competitor for $2.5 Million to Expand Natural-Product Offerings	06.05.
LSL Pharma Group Enters Into Binding Agreement to Acquire Quebec Competitor	06.05.
LSL Pharma Group Inc. entered into a binding Letter of Intent to acquire Target Co for CAD 2.5 million.	06.05.
LSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and Highlights	30.04.
LSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and Highlights	30.04.
LSL Pharma Group Brief: Said Earlier Wednesday It Secured $3.8 Million As the Second And Final Tranche Of Its Private Placement Of Units	24.04.
LSL Pharma Group Secures $3.8 Million as the Second and Final Tranche of Its Private Placement of Units	24.04.
LSL Pharma Group Inc. announced that it has received CAD 6.479426 million in funding from Alfera Pharmaceuticals, LLC	24.04.
LSL Pharma Group Announces the Addition of New Members to Its Board of Directors	23.04.
LSL Pharma Group Announces the Addition of New Members to Its Board of Directors	23.04.
LSL Pharma Group Inc. Appoints Diane Beaudry and Mario Paradis to Its Board of Directors	23.04.
LSL Pharma Group Brief: Has Upsized Its Private Placement From $3.5 Million To $7.5 Million	11.04.
LSL Pharma Group Announces the Upsizing of Its Private Placement From $3.5 Million to $7.5 Million	11.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen LSL Pharma Group Inc.

Aktien

LSL

CA50190N1042

LSL

Andere Sprachen

Filter